{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:49:24Z","timestamp":1791492564170,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41443-025-01197-1","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:19:19Z","timestamp":1760948359000},"page":"747-754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intralesional baicalein attenuates fibrosis in a rat model of peyronie\u2019s disease by inhibiting TGF-\u03b21\/smad signaling"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6848-9506","authenticated-orcid":false,"given":"Kadir Can","family":"Sahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyyaz","family":"Irmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Hamza","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Gokbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3768-1589","authenticated-orcid":false,"given":"Sima","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iclal","family":"Gurses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Akkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdi","family":"Ozkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"1197_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s0022-5347(01)65361-8","volume":"157","author":"CJ Devine","year":"1997","unstructured":"Devine CJ, Somers KD, Jordan GH, Schlossberg SM. Proposal: trauma as the cause of the Peyronie\u2019s lesion. J Urol. 1997;157:285\u201390. https:\/\/doi.org\/10.1016\/s0022-5347(01)65361-8.","journal-title":"J Urol"},{"key":"1197_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/sj.ijir.3900880","volume":"14","author":"S Sikka","year":"2002","unstructured":"Sikka S, Hellstrom W. Role of oxidative stress and antioxidants in Peyronie\u2019s disease. Int J Impot Res. 2002;14:353\u201360. https:\/\/doi.org\/10.1038\/sj.ijir.3900880.","journal-title":"Int J Impot Res"},{"key":"1197_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/s1089-8603(02)00124-6","volume":"7","author":"D Vernet","year":"2002","unstructured":"Vernet D, Ferrini MG, Valente EG, Magee TR, Bou-Gharios G, Rajfer J, et al. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie\u2019s fibrotic plaque and in its rat model. Nitric Oxide. 2002;7:262\u201376. https:\/\/doi.org\/10.1016\/s1089-8603(02)00124-6.","journal-title":"Nitric Oxide"},{"key":"1197_CR4","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/j.1743-6109.2009.01584.x","volume":"7","author":"EL Rhoden","year":"2010","unstructured":"Rhoden EL, Riedner CE, Fuchs SC, Riberio EP, Halmenschlager G. A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie\u2019s disease. J Sex Med. 2010;7:1529\u201337. https:\/\/doi.org\/10.1111\/j.1743-6109.2009.01584.x.","journal-title":"J Sex Med"},{"key":"1197_CR5","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/S0022-5347(01)65579-4","volume":"156","author":"DA Nachtsheim","year":"1996","unstructured":"Nachtsheim DA, Rearden A. Peyronie\u2019s disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology. J Urol. 1996;156:1330\u20134. https:\/\/doi.org\/10.1016\/S0022-5347(01)65579-4.","journal-title":"J Urol"},{"key":"1197_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/s0022-5347(17)52751-2","volume":"128","author":"LM Nyberg","year":"1982","unstructured":"Nyberg LM, Bias WB, Hochberg MC, Walsch PC. Identification of an inherited form of peyronie\u2019s disease with autosomal dominant inheritance and association with dupuytren\u2019s contracture and histocompatibility B7 cross-reacting antigens. J Urol. 1982;128:48\u201351. https:\/\/doi.org\/10.1016\/s0022-5347(17)52751-2.","journal-title":"J Urol"},{"key":"1197_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1464-410x.1998.00529.x","volume":"181","author":"AI El-Sakka","year":"1998","unstructured":"El-Sakka AI, Hassan MU, Nunes L, Bhatnagar RS, Yen TS, Lue TF. Histological and ultrastructural alterations in an animal model of peyronie\u2019s disease. Br J Urol. 1998;181:445\u201352. https:\/\/doi.org\/10.1046\/j.1464-410x.1998.00529.x.","journal-title":"Br J Urol"},{"key":"1197_CR8","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/s0022-5347(01)68236-3","volume":"158","author":"AI El-Sakka","year":"1997","unstructured":"El-Sakka AI, Hassoba HM, Chui RM, Bhatnagar RS, Dahiya R, Lue TF. An animal model of Peyronie\u2019s-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol. 1997;158:2284\u201390. https:\/\/doi.org\/10.1016\/s0022-5347(01)68236-3.","journal-title":"J Urol"},{"key":"1197_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI115821","volume":"90","author":"WA Border","year":"1992","unstructured":"Border WA, Ruoslahti E. Transforming growth factor-b in disease. the dark side of tissue repair. J Clin Invest. 1992;90:1\u20137. https:\/\/doi.org\/10.1172\/JCI115821.","journal-title":"J Clin Invest"},{"key":"1197_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4111\/kju.2012.53.1.44","volume":"53","author":"JH Jang","year":"2012","unstructured":"Jang JH, Ryu JK, Suh JK. Activin receptor-like kinase 5 inhibitor attenuates fibrosis in fibroblasts derived from Peyronie\u2019s plaque. Korean J Urol. 2012;53:44\u20139. https:\/\/doi.org\/10.4111\/kju.2012.53.1.44.","journal-title":"Korean J Urol"},{"key":"1197_CR11","volume-title":"Phytochemistry Research Progress","author":"T Matsumoto","year":"2013","unstructured":"Matsumoto T. Phytochemistry Research Progress. New York: Nova Science Publishers Inc; 2013."},{"key":"1197_CR12","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1016\/j.bmc.2006.01.057","volume":"14","author":"JD Deschamps","year":"2006","unstructured":"Deschamps JD, Kenyon VA, Holman TR. Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases. Bioorg Med Chem. 2006;14:4295\u2013301. https:\/\/doi.org\/10.1016\/j.bmc.2006.01.057.","journal-title":"Bioorg Med Chem"},{"key":"1197_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/jb\/mvp148","volume":"147","author":"K Miyazono","year":"2010","unstructured":"Miyazono K, Kamiya Y, Morikawa M. Bone morphogenetic protein receptors and signal transduction. J Biochem. 2010;147:35\u201351. https:\/\/doi.org\/10.1093\/jb\/mvp148.","journal-title":"J Biochem"},{"key":"1197_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/bjd.14108","volume":"174","author":"YF Zhang","year":"2016","unstructured":"Zhang YF, Zhou SZ, Cheng XY, Yi B, Shan SZ, Wang J, et al. Baicalein attenuates hypertrophic scar formation via inhibition of the transforming growth factor-\u03b2\/Smad2\/3 signalling pathway. Br J Dermatol. 2016;174:120\u201330. https:\/\/doi.org\/10.1111\/bjd.14108.","journal-title":"Br J Dermatol"},{"key":"1197_CR15","unstructured":"Salonia A, Bettocchi C, Capogrosso P, Carvalho J, Corona G, Dinkelman-Smith M, et al. EAU Guidelines on Sexual and Reproductive Health 2024. Arnhem, The Netherlands: EAU Guidelines Office; 2024. ISBN 978-94-92671-23-3."},{"key":"1197_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","volume":"194","author":"A Nehra","year":"2015","unstructured":"Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, et al. Peyronie\u2019s Disease: AUA Guideline. J Urol. 2015 Sep;194:745\u201353. https:\/\/doi.org\/10.1016\/j.juro.2015.05.098.","journal-title":"J Urol"},{"key":"1197_CR17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner E, Lang AG. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149\u20131160. https:\/\/doi.org\/10.3758\/BRM.41.4.1149.","journal-title":"Behav Res Methods"},{"key":"1197_CR18","doi-asserted-by":"publisher","first-page":"6116890","DOI":"10.1155\/2021\/6116890","volume":"2021","author":"H Bai","year":"2021","unstructured":"Bai H, Yuan R, Zhang Z, Liu L, Wang X, Song X, et al. Intra-articular injection of baicalein inhibits cartilage catabolism and NLRP3 inflammasome signaling in a posttraumatic OA model. Oxid Med Cell Longev. 2021;2021:6116890 https:\/\/doi.org\/10.1155\/2021\/6116890.","journal-title":"Oxid Med Cell Longev"},{"key":"1197_CR19","doi-asserted-by":"publisher","first-page":"qfad046","DOI":"10.1093\/sexmed\/qfad046","volume":"11","author":"F Castiglione","year":"2023","unstructured":"Castiglione F, Cakir OO, Schifano N, Corona G, Reisman Y, Bettocchi C, et al. European society of sexual medicine consensus statement on the use of animal models for studying peyronie\u2019s disease. Sex Med. 2023;11:qfad046 https:\/\/doi.org\/10.1093\/sexmed\/qfad046.","journal-title":"Sex Med"},{"key":"1197_CR20","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.juro.2012.08.191","volume":"189","author":"E Chung","year":"2013","unstructured":"Chung E, Garcia F, De Young L, Solomon M, Brock GB. A comparative study of the efficacy of intralesional verapamil versus normal saline injection in a novel Peyronie disease animal model: assessment of immunohistopathological changes and erectile function outcome. J Urol. 2013;189:380\u20134. https:\/\/doi.org\/10.1016\/j.juro.2012.08.191.","journal-title":"J Urol"},{"key":"1197_CR21","doi-asserted-by":"publisher","first-page":"e682","DOI":"10.1016\/j.juro.2012.02.1586","volume":"187","author":"F Garcia","year":"2012","unstructured":"Garcia F, De Young L, Chung E, Brock M, Brock G. A durable novel rat model for Peyronie\u2019s disease. J Urol. 2012;187:e682\u2013e683. https:\/\/doi.org\/10.1016\/j.juro.2012.02.1586.","journal-title":"J Urol"},{"key":"1197_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1538\/expanim.18-0003","volume":"67","author":"A Tsukamoto","year":"2018","unstructured":"Tsukamoto A, Niino N, Sakamoto M, Ohtani R, Inomata T. The validity of anesthetic protocols for the surgical procedure of castration in rats. Exp Anim. 2018;67:329\u201336. https:\/\/doi.org\/10.1538\/expanim.18-0003.","journal-title":"Exp Anim"},{"key":"1197_CR23","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18:e3000410 https:\/\/doi.org\/10.1371\/journal.pbio.3000410.","journal-title":"PLoS Biol"},{"key":"1197_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12906-023-03885-1","volume":"23","author":"B Peng","year":"2023","unstructured":"Peng B, Hu Q, He R, Hou H, Lian D, Chen Y, et al. Baicalein alleviates fibrosis and inflammation in systemic sclerosis by regulating B-cell abnormalities. BMC Complement Med Ther. 2023;23:62 https:\/\/doi.org\/10.1186\/s12906-023-03885-1.","journal-title":"BMC Complement Med Ther"},{"key":"1197_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5483\/bmbrep.2010.43.4.297","volume":"43","author":"EK Kong","year":"2010","unstructured":"Kong EK, Huang Y, Sanderson JE, Chan KB, Yu S, Yu CM. Baicalein and wogonin inhibit collagen deposition in SHR and WKY cardiac fibroblast cultures. BMB Rep. 2010;43:297\u2013303. https:\/\/doi.org\/10.5483\/bmbrep.2010.43.4.297.","journal-title":"BMB Rep"},{"key":"1197_CR26","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1111\/jcmm.16538","volume":"25","author":"B Li","year":"2021","unstructured":"Li B, Chen K, Qian N, Huang P, Hu F, Ding T, et al. Baicalein alleviates osteoarthritis by protecting subchondral bone, inhibiting angiogenesis and synovial proliferation. J Cell Mol Med. 2021;25:5283\u201394. https:\/\/doi.org\/10.1111\/jcmm.16538.","journal-title":"J Cell Mol Med"},{"key":"1197_CR27","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.21037\/apm-20-2389","volume":"10","author":"WJ Li","year":"2021","unstructured":"Li WJ, Bao J, Zheng DC, Guo J, Xie MK, Chen HY, et al. Treatments of Peyronie\u2019s disease with Scutellaria baicalensis and surgery according to the disease course: a single-center retrospective study of 261 patients. Ann Palliat Med. 2021;10:2979\u201389. https:\/\/doi.org\/10.21037\/apm-20-2389.","journal-title":"Ann Palliat Med"},{"key":"1197_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/RRU.S109319","volume":"8","author":"G Paulis","year":"2016","unstructured":"Paulis G, Romano G, Paulis A. Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie\u2019s disease: a retrospective analysis of 309 cases. Res Rep Urol. 2016;8:95\u2013103. https:\/\/doi.org\/10.2147\/RRU.S109319.","journal-title":"Res Rep Urol"},{"issue":"Suppl 1","key":"1197_CR29","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1038\/sj.ijir.3900792","volume":"14","author":"E Wespes","year":"2002","unstructured":"Wespes E. Smooth muscle pathology and erectile dysfunction. Int J Impot Res. 2002;14(Suppl 1):S17\u2013S21. https:\/\/doi.org\/10.1038\/sj.ijir.3900792.","journal-title":"Int J Impot Res"},{"key":"1197_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41443-019-0138-7","volume":"32","author":"T Antoniassi","year":"2020","unstructured":"Antoniassi T, Facio Junior FN, Spessoto LC, Guerra LH, Campos SS, Taboga S. Anti-fibrotic effect of mycophenolate mofetil on Peyronie\u2019s disease experimentally induced with TGF-\u03b2. Int J Impot Res. 2020;32:201\u20136. https:\/\/doi.org\/10.1038\/s41443-019-0138-7.","journal-title":"Int J Impot Res"},{"key":"1197_CR31","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.jsxm.2017.08.011","volume":"14","author":"H Lin","year":"2017","unstructured":"Lin H, Liu C, Wang R. Effect of penile traction and vacuum erectile device for peyronie\u2019s disease in an animal model. J Sex Med. 2017;14:1270\u20136. https:\/\/doi.org\/10.1016\/j.jsxm.2017.08.011.","journal-title":"J Sex Med"},{"key":"1197_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.esxm.2018.09.003","volume":"7","author":"F Castiglione","year":"2019","unstructured":"Castiglione F, Hedlund P, Weyne E, Hakim L, Montorsi F, Bivalacqua TJ, et al. Intratunical injection of human adipose tissue-derived stem cells restores collagen III\/I ratio in a rat model of chronic peyronie\u2019s disease. Sex Med. 2019;7:94\u2013103. https:\/\/doi.org\/10.1016\/j.esxm.2018.09.003.","journal-title":"Sex Med"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01197-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01197-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:02:49Z","timestamp":1791489769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01197-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1038\/s41443-025-01197-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6752805\/v1","asserted-by":"object"}]},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":": E-74555795-050.01.04-794309.","order":2,"name":"Ethics","label":"Ethics committee approval number","group":{"name":"EthicsHeading","label":"Ethics"}}]}}